Big cargo gene therapy

With a proven track record in biopharmaceuticals, we aim to revolutionize advanced gene therapy to address unmet patient needs.

Cancers and liver diseases

We aim to create best-in-class bacteria-based therapies for unmet patient needs. Our current therapeutic focus includes pancreatic cancer, colorectal cancer, cervical cancer and liver diseases, while we continue to seek new medical applications. Preclinical research collaborations with pharma & biotech companies are an important pillar of our strategy.

Redbiotec News

Outlook 2020

December 18th, 2019|

We thank you for your trust and support in 2019 and we wish you all the best in the forthcoming [...]